Literature DB >> 11552945

Thymic stromal cells and positive selection.

A P Chidgey1, R L Boyd.   

Abstract

The intrathymic differentiation events leading to the development and export of mature T cells tolerant to self yet capable of responding to foreign peptide antigen in the context of self-MHC are clearly both dynamic and complex. The changing phenotype of the developing thymocyte as it migrates through and interacts with the heterogeneous thymic microenvironment and the intracellular signalling events associated with such interactions are being extensively studied, yet many aspects remain poorly defined, such as the precise relationship between stromal cells and thymic selection. Positive and negative selection are crucial events in the development of T cells, leading to a diverse yet non-autoreactive immune system. A breakdown in either of these processes could lead to either a reduced T cell repertoire or the escape into the periphery of autoreactive T cells - both clearly having deleterious consequences for the health of the individual. This review aims to summarise the current status of research in thymic positive selection with emphasis on the role of different cell types and peptides.

Mesh:

Substances:

Year:  2001        PMID: 11552945     DOI: 10.1111/j.1600-0463.2001.apm090701.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  Thymus transplantation.

Authors:  M Louise Markert; Blythe H Devlin; Elizabeth A McCarthy
Journal:  Clin Immunol       Date:  2010-03-16       Impact factor: 3.969

Review 2.  THEMIS: Two Models, Different Thresholds.

Authors:  Seeyoung Choi; Richard Cornall; Renaud Lesourne; Paul E Love
Journal:  Trends Immunol       Date:  2017-07-08       Impact factor: 16.687

3.  Type 1 cytokines polarize thymocytes during T cell development in adult thymus organ cultures.

Authors:  Barbara J Whalen; Jan Marounek; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Autoimmun       Date:  2003-02       Impact factor: 7.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.